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Summary: The catalytic activities of 4 glycosidases (hyaluronate-4-glycanohydrolase (EC 3.2.1.35), ß-N-
acetyl-D-glucosaminidase (EC 3.2.1.30), ß-glucuronidase (EC 3.2.1.31), -L-iduronidase (EC 3.2.1.76)), of
the arylsulphatases A and B (EC 3.1.6.1) and of the protease cathepsin D (EC 3.4.23.5) were measured in
extracts from hepatocytes and non-parenchymal cells and in serum during the development of thioacetamide-
induced rat liver fibrosis (22 weeks). In non-parenchymal liver cells the catalytic activities of ß-N-acetyl-D-
glucosaminidase, ß-glucuronidase, -L-iduronidase and cathepsin D were increased significantly during
chronic liver damage, but that of hyaluronate-4-glycanohydrolase was reduced by 40 to 65% during the
period of applicätion of thioacetamide. The catalytic activities of the arylsulphatases were lowered by 65%
compared to control values in the 12th week but with advancing liver damage the catalytic activities returned
to nearly normal values. Parenchymal cells of rats, which had been liver-damaged for 6 months, contained
strongly elevated activities of ß-glucuronidase, ß-N-acetyl-D-glucosaminidase, arylsulphatases A and B, and
cathepsin D but only slightly increased activities of hyaluronate-4-glycanohydrolase and -L-iduronidase, re-
spectively.
In the serum of liver-damaged rats the activity of -L-iduronidase was strongly elevated, while that of N-
acetyl-ß-D-glucosaminidase was only slightly increased. The activities of ß-glucuronidase and of arylsulpha-
tases A and B were decreased during the whole period of treatment. The catalytic functions of hyaluronate-4-
glycanohydrolase and of cathepsin D, respectively, were decreased initially, but both enzyme activities were
elevated during the more advanced stages of long term thioacetamide treatment.
Aktivitätsänderungen Proteoglykan^abbauender^ lysosomaler Enzyme in Parenchym- und Nicht-Parenchym-
zellen der Leber sowie im Serum während der Entwicklung einer experimentellen Leberfibrose
Zusammenfassung: Die katalytischen Aktivitäten von vier Glykosidasen (Hyaluronat-4-glykanohydrolase
(EC 3.2.1.35), ß-N-Acetyl-D-glucosaminidase (EC 3.2.1.30), ß-Glucuronidase (EC 3.2.1.31), cc-L-
Iduronidase (EC 3.2,1.76)) sowie zweier Sulfatasen (Arylsulfatase A und B) (EC 3.1.6.1) und einer Protease
/(Kathepsin D) (EC 3.4.23.5) wurden in den löslichen Extrakten von Hepatocyten und Nicht-Parenchym-
zellen der Leber und im Serum im Verlaufe einer Thioacetamid-induzierten Leberfibrose (22 Wochen)
bestimmt. In Nicht-Parenchymzellen sind die katalytischen Aktivitäten der ß-N-Acetyl-£>-glucosaminidase,
ß-Glucuronidase, -L-Idufonidase und Kathepsin D bei chronischer Leberschädigung signifikant erhöht,
wohingegen die katalytische Aktivität der Hyaluronat-4-glykanohydrolase im gesamten Untersuchungs-
zeitraum um 40 bis 65% vermindert ist. Die katalytischen Aktivitäten der Arylsulfatasen A und B waren in
der 12. Woche der Schädigung um 65% erniedrigt (verglichen mit den Kontrollen), mit fortschreitender
Leberschädigung wurden jedoch wieder Normalwerte erreicht. Parenchymzellen von Ratten, die 6 Monate
mit Thioacetamid geschädigt waren, zeigten stark erhöhte katalytische Aktivitäten der ß-Glucuronidase, der
ß-N-Acetyl-D-glucosaminidase, der Arylsulfatasen A und B, des Kathepsin D, aber nur gering erhöhte
katalytische Aktivitäten der Hyaluronat-4-glykanohydrolase und der a-L-Iduronidase.
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Im Serum geschädigter Ratten wurden stark erhöhte katalytische Aktivitäten der -L-Iduronidase festge-
stellt, wohingegen die der ß-N-Acetyl-D-glucosaminidase nur leicht erhöht war. Die katalytischen Aktivi-
täten der ß-Glucuronidase und der Arylsulfatasen A und B waren während des gesamten Behandlungszeit-
raums vermindert. Die katalytischen Funktionen der Hyaluronat-4-glykanohydrolase und des Kathepsin D
waren initial erniedrigt, in fortgeschrittenen Stadien der langzeitigen Thioacetamid-Behandlung wiesen beide
Enzyme deutliche Aktivitätssteigerungen auf. . r
Introduction
Proteoglycans äs well äs glycosaminoglycans play an
important role in pathobiochemical changes of many
liver diseases especially in the course of the fibrotic
transformation of the organ (1,2). According to sev-
eral authors (3-8), the proteoglycans and glycosa-
minoglycans of'fibrotic human liver and of experi-
mental fibrotic animal liver show significant in-
creases, molecular changes and topohistological dis-
tortions. These changes occur chiefly in the hyaluro-
nate, chondroitin, sulphate and dermatan sulphate
fractions. The extensive accumulation of intercellu-
lar glycosaminoglycans in cirrhotic and fibrotic liver
tissue is mainly ascribed to active mechanisms like
enhanced synthesis (9—12), but the knowledge of
contributory mechanisms is scanty. Passive processes
like the deposition of extrahepatically synthesized
proteoglycans in the liver (13, 14) and/or Inhibition
of hepatic glycosaminoglycan degradation by re-
duced lysosomal enzyme activities in chronically in-
jured liver tissue are possible, but äs yet experimen-
tally unproven. Since both hepatocytes and non-par-
enchymal liver cells (mainly Kupffer cells and en-
dothelial cells) contain a whole set of glycosamino-
glycan degrading lysosomal enzymes (15^21) the
activities of several important glycosidases, (hyalur-
onate-4-glycanohydrolase, ß-D-glucuronidase, ß-N-
acetyl-D-glucosaminidase, -L-iduronidase), of two
sulphatases (arylsulphatases A and B) and of one
protease (cathepsin D) were studied in both cell
types, and, additionally, in the serum of normal and
chronically injured rats. These experiments were
performed to elucidate the role of the lysosomal gly-
cosaminoglycan-degrading enzyme System in the de-
velopment of thioacetamide-induced liver fibrosis.
Materials and Methods
Chemicals
Pronase was obtained from Calbiochem-Behring, La Jolla,
U.S.A.; collagenase (type I), triton X-100 and the enzyme Sub-
strates p-nitrophenyl-ß-D-glucuronide, p-nitrophenyl-N-acetyl-
&-D-glucosaminide, p-nitrocatechol-sulphate, hyaluronic acid
(grade I) and bovine haemoglobin (type II) were from Sigma
Chemical Comp. Munich, FRG; Hank's balanced salt solution
and. Dulbeccos modification of Eagles medium were purchased
from Flow Laboratories GmbH, Bonn, FRG; thioacetamide was
from E. Merck AG, Darmstadt; phehyl^a-L-iduronide was a gen-
erous gift from Dr. B. Weissmann of trie Umversity pf Illinois,
U.S.A. All other chemicals were p. a. quality from E. Merck AG,
Darmstadt.
Treatment of the animals
Male Sprague-Dawley rats (Lippische Versuchstiefzucht, Exter-
tal, FRG), weighing 200—250 g, were used. The rats were fed a
Standard rat diet and received water ad libitum. Half of the rats
received cofitinüoüsly thioacetamide in the drinking water at a
concentfation of 0.3 g/l during the whole experimental period of
22 weeks. The other half pf the rats received normal water with-
out the toxic agent (coatrol rats).
After varipus time periods, experimental and control rats were
anaesthetized with Nembutal (Serva, Heidelberg), l^2 ml of
blood was aspirated from V. cava inferior and the liver was cannu-
lated via the portal vein to prepafe parenchymal and non-paren-
chymal cells äs described below.
Preparation of -parenchymal cells
The liver was first perfused in a non^circulating manner (flow rate
30 ml/min) via the portal vein for 3-5 min at 37 °C with oxygen^
ated Ca?+-free Hank's balanced salt solution, containing 0.03
mol/1 of NaHCQ3. Hank's balanced salt solution (10ml) contain^
ing 5 mmol/1 Ca*+ and 2 g/l pronase was then injected (22). The
"liver was removed, transfered into a Petri dish with buffer and
carefully disintegrated at room temperatüre. After oxygenation
with O2/CO2 (fractions 0.95/0.05) for 2 min, the liver fragments
were incubated under constant agitation for l h at 37 °C in Hank's
balanced salt solution containing Ca2+ and pronase. Thereafter,
the tissue^cell Suspension was filtered through sterile gauze, ceri-
trifuged for 5 min at 610 g and resuspended in cold washing buffer
according to Seglen (23). Non-parenchymal cells were purified
by washing, and the final cell preparation was suspended in a
small volume of Dulbecco's modification of Eagles medium. The
viability of the cells checked by the trypan blue exclusipn test was
around 92%, the contamination with parenchymal cells was less
than 1%.
Preparat ion of liver parenchymal cells
Hepatocytes were prepared by a two-step perfusion procedure es-
sehtially aceording to Seglen (23—25). The organ was initially
perfused in situ for 10 min in a non circulating wäy via the portal
vein with Ca—free oxygenated Hank's balanced salt solution at a
flow rate of 30 ml/min. Thereäfter, reeirculating perfüsiop was
performed for a further 10 min at a flow rate of 50 ml/min with
Hank's balanced salt solution eontaining 0.5 g/l collagenase and
5 mmol/1 Ca2+. The medium was continuously gassed with Ü2/
CO2 (fractions 0.95/0.05). After finishing the perfusion, the liver
capsule was carefully removed and the tissue dissected. The re-
sulting initial cell Suspension was filtered through sterile gauze
and then through nylon filters of different pore size (250,
100 ). The filtered cells were centrifuged for 2 min at 36 g and
4 °C, gently resuspended and washed two times by centrifugation
(2min, 17g, 4°C). The final cell sediment was resuspended in
Dulbecco's modification of Eagles medium. More than 90% of
hepatocytes excluded trypan blue, the eontamination with non-
parenchymal cells was about 1—2%. v ;
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Homogenizat ion of cells
Ice-cold Triton-X-100 (l g/I) solution was added to the purified
parenchymal and non-parenchymal cells which had been adjusted
to a cell concentration of l x 1010/1. After incubation for 25 min
at 4 °C, the Suspension was homogenized at 0—4 °C in a Potter-El-
vehjem homogenizer. Cell debris were separated from the homo-
genate by centrifugation (1000g, 5min, 4°C). The supernatant
was diluted with ice-cold distilled water.
Protein was determined in the cell extract according to the meth-
od of Bradford (26) using bovine γ-globulin s a Standard (Bio
Rad Laboratories, Munich, FRG).
Collection of serum
Blood (1-2 ml) was aspirated from the V. cava inferior prior to
the perfusion of the liver. After complete coagulation blood was
centrifuged and the serum diluted with cold 0.15 mol/1 NaCl.
Enzyme catalytic activities were determined immediately after
obtaining the sera and the cell extracts, respectively.
De te rmina t ion of lysosomal enzyme catalytic activi-
ties
-N-acetyl-O-glucosamidase (EC 3.2.1.30) was determined with
p-nitrophenyl-N-acetyl- -jD-glucosaminide s Substrate in 0.1
mol/1 sodium citrate buffer, pH 4.3 (27); -glucuronidase (EC
3.2.1.31) was determined with/7-nitropHenyl- -D-glucuronide s
Substrate according to the method described by Hall (28) with
slight modifications. Arylsulphatase A and arylsulphatase B (EC
3.1.6.1) were determined spectrophotometrically with 2-hydroxy-
5-nitrophenylsulphate s Substrate in 0.25 mol/1 sodium acetate
buffer, pH 5.0 and pH 6.0, respectively (27,29). The catalytic ac-
tivity of cathepsin D (EC 3.4.23.5) was measured in 0.25 mol/1
sodium formate buffer, pH 3.3 with denatured bovine haemp-
globin s Substrate (27). The concentration of the liberated pep-
tides was determined by the Lowry procedure (30).
Hyaluronate-4-gIycanohydrolase (EC 3.2.1.35) was assayed with
hyaluronic acid s Substrate in 0.25 mol/1 sodium formate buffer,
pH 3.8 (27). The activity of α-L-iduronidase (EC 3.2.1.76) was
measured with phenyliduronide s Substrate according to the
method described by Hall (28) with a minor modification.
The activities of the enzymes are refered to the concentration of
protein in the cell extracts. Under all assay conditions enzyme ac-
tivities were linear with time of incubation and concentration of
cell extracts and serum, respectively.
Results
Lysosomal enzyme catalytic activities in rat liver non-
parenchymal cells during thioacetamide^induced liver
fibrosis
,The continuous application of thioacetamide to rats
generates liver fibrosis. This process is accompanied
by an elevation of most of the studied lysosomal en-
zyme catalytic activities in non-parenchymal liver
cells. The enzymes -glucuronidase and cathepsin D
are enhanced 2.6 and 1.9 fold, respectively, 3 weeks
after Initiation of liver damage (fig. lb, 2c). While'
the catalytic activities of these enzymes decrease in
the further course of liver damage, the glycosidases
a-L-iduronidase and -N-acetyl-D-glucosaminidase
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Fig. l. Specific catalytic activities of 4 lysosomal glycosidases in
rat liver non-parenchymal cells during the development of
thi acetamide-induced liver fibrosis: hyaIuronate-4-gly-
canohydrolase (a), -glucuronidase (b), -N-acetyl-D-
glucosaminidase (c) and α-L-iduronidase (d).
Open columns represent enzyme catalytic activities in
nonparenehymal cells of control rats, black columns rep-
resent those in non-parenchymal cells from treated rats.
Each value is the mean ± S. D. of preparations from 6
different rats. For further details see materials and meth-
ods.
and 2.8 fold, respectively, above normal) after 22
weeks (fig. 1). The catalytic activity of arylsulphatase
B was elevated 1.7 fold in the third week, whereas
that of arylsulphatase A remained in the normal
r nge at this time point. In the further course of
chronic liver damage both arylsulphatases decrease
in catalytic activity (fig. 2a, b). The activity profile of
the lysosomal hyaluronate-4-glycanohydrolase was
found to be quite different from that of the other
enzyihes (fig. l a); during the whole period of
thioacetamide application the catalytic activity was
significantly reduced, in general between 30 and
60% of that assayed in non-parenchymal cells from
untreated rats.
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Fig. 2. Specific catalytic activities of lysosomal arylsulphatases A
(a) and B (b) and cathepsin D (c) in rat liver non-paren-
chymal cells during thioacetamide-induced liver fibrosis.
Open columns represent enzyme catalytic activities in
non-parenchymal cells of control rats, black columns
represent those in cells from treated rats. Each value is the
mean ± S. D. of preparations from 6 different rats. For
further details see materials and methods.
Lysosomal enzyme catalytic activities in serum of rats,
during induced liver fibrosis
Long term thioacetamide-induced liver injury is ac-
companied by reduced catalytic activities of most of
the lysosomal enzymes studied in serum (fig. 3, 4).
The catalytic activities of ß-glucuronidase and aryl-
sulphatase A were found to be diminished through-
out the whole period of liver injury (fig. 3b, 4a). The
catalytic activities of four of the enzymes studied,
i. e. hyahironate-4-glycanohydrolase, ß-N-acetyl-D-
glucosaminidase, arylsulphatase B and cathepsin D
showed a tendency to increase during long time liver
damage (fig. 3a, c, fig. 4b, c). The catalytic activity of
cathepsin D in serum was 3.5 fold above normal in
the 22th week. The enzyme profile öf a-L-idüroni-
dase was quite different from that of the other en-
zymes; over the whole experimental period the cata-
lytic activity was greatly increased (3 fold above nor-
mal) reaching a maximum at the 7th week (fig. 3d).
1 2 3 4 5 6 7 8 9 10 11 12 13 22 23
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Fig. 3. Catalytic activity concentrations of 4 glycosidases in rat
serum over the whole thioacetamide application period:
hyaluronate-4-glycanohydrolase (a), ß-glucuronidase (b),
ß-N^acetyl^D-glücosaminidase (c) and a-L-iduronidase
(d).
Open columns represent the enzyme catalytic activities in
the sera of control rats, black columns repfesent those in
the sera of treated rats. Each value is the mean + S.D.
frorri 6 different rats. For fürther details see materials and
methods.
Lysosomal enzyme catalytic activities in hepatocytes
from long term liver damaged rats
As shown in figure 5 the catalytic activities of the
glycosidases, arylsulf atases A and B and of eathepsin
D are increased in hepatocytes from rats which were
liver-damaged for 6 moriths with thioacetamide.
With the exeeptions of hyaluronate-4-glycanoliydro-
lase and -L-iduronidase, which were onjy slightly
elevated, other enzyme catalytic activities were in»
creased about'2-fold in hepatocytes froin lorig term
damaged liver (fig. 5).
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Fig. 4. Catalytic activity concentrations of arylsulfatase A (a) and
B (b) and of cathepsin D (c) in rat serum over the whole
thioacetamide application period.
Open coiumns represent the enzyme catalytic activity con-
centrations in serum of control rats, black coiumns repre-
sent those in serum of treated rats. Each value is the
mean ± S. D. of 6 preparations. For further detäils see
materials and methods.
Discussion
The experiments described here demonstrate an in-
crease in the catalytic activities of ß-glucuronidase,
ß-N-acetyl-D-glucosaminidase, a-L-iduronidase
and cathepsin D in non-parenchymal liver cells dur-
ing the development of experimental liver fibrosis.
The same enzymes were also more catalytically ac-
tive in extracts from hepatocytes of chronically dam-
aged liver (6 months) than in those, isolated from
normal liver. It is of great interest that the catalytic
activity of hyaluronate-4-glycanphydrolase was
found to be significantly diminished in non-paren-
chymal cells over the whole experimental period. In
hepatocytes, the catalytic activity of this enzyme was
only slightly stimulated. A similar decrease of hya-
luronate-4-glycanohydrolase catalytic activity in to-
tal liver was described by Hutterer (31) in the irre-
versible stage of experimental fibrosis, but in the in-
itial stage (reversible fibrosis) an increase of catalytic
activity was found. The data are at variance with
those of Nakamura et al., who reported an increase
of this enzyme catalytic activity in CCl4-damaged liv-
er (32). The lysosomal hyaluronate-4-glycanohydro-
lase degrades hyaluronate and, at a slower rate,
chondroitin-4-sulphate, chondroitin-6-sulphate and
dermatan sulphate (33). The reduced catalytic activ-
ity of this endoglycosidase might be responsible for
the accumulation of the respective types of glycosa-
minoglycans, in particular of chondroitin sulphate,
dermatan sulphate and hyaluronate (4, 8) in fibrotic
liver. The increase ifi the catalytic activities of the







































Fig. 5. Specific catalytic activities of lysosomal enzynies in parenchymal liver cells of rats injured for 6 months with thioacetamide.
Open coiumns represent specific catalytic activities of parenchymal cells isolated from control rats, black coiumns those in
hepatocytes from treated rats. Each value is the mean ± S. D. for preparations from 6 different rats. For further detäils see
materials and methods.
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possible Inhibition of the degradation of glycos-
aminoglycans due to a decrease of endoglycosidically
active hyaluronate-4-glycanohydfolase; the former
enzymes act mainly on oligosaccharides (34, 35),
and in the case of chondroitin sulphate and dermätan
sulphate they act on the desulphated oligosaccha-
rides at the non-reducing terminal (36). The impor-
tant role of hyaluronate-4-glycanohydrolase in the
catabolism of liver glycosaminoglycans is suggested
by Constantopoulos et al. (37) from studies with the
trypanocidal drug suramin. In the presence of this
drug the strong Inhibition of the enzyme is accom-
panied by an increase in the total glycosaminoglycan
concentration in rat liver tissue.
Our results describe reduced catalytic activities of
both arylsulphatases in advanced stages of the devel-
opment of liver fibrosis. The deficiency of the aryl-
sulphatase B, which cleaves the C4-sulfate groups
from glycosaminoglycans might also be rel^ted to the
accumulation of chondroitin-4-sulphate and dermä-
tan sulphate in liver parenchyma, äs found in the
Maroteaux-Lamy syndrome (38, 39), where the ge-
netically caused lack of arylsulphatase B results in
tissue storage and urinary excretion of chondroitin
sulphate and dermätan sulphate. According to this
pathologic condition the reduced catalytic activity of
arylsulphatase B, äs it is demonstrated here, could
impair the degradation of glycosaminoglycans.
With the exception of the significant increase in cata-
lytic activity of -L-iduronidase and cathepsin D in
terminal stages of chronic injury the catalytic activity
of the other lysosomal enzymes were found to be de-
creased or only slightly stimulated in the sera of
treated rats. A moderate increase of iß-N-acetyl-D-
glucosaminidase catalytic activity (32, 40) and hya-
luronate-4-glycanohydrolase catalytic activity (32)
in sera of rats with chronic hepatic damage was ob-
served previously, but the profile of other glycosa-
minoglycan-degrading lysosomal enzymes of liver-
injured rats has not been reported. Although the pa-
thobiochemical mechanism of our finding is not yet
clear, disturbänees in the balanced transport equili-
brium of lysosomal enzymes between lysosomes and
the extracellular space might be responsible for the
increase of catalytic activities in the cells and the sl·
multaneous decrease in serum during initial stages of
injury (41). The pattern of lysosomal enzyme eata-
lytic activity in the serum of chrönically liVef-däm^
aged rats does not suggest any enzyme äs a biochem-
ical marker of experimental liver fibrosis, since the
changes were often only moderate and strongly de-
pendent on the tirhe point of chronic liver damage.
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